BJBithiah Grace Jaganathan

Bithiah Grace Jaganathan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bithiah Grace Jaganathan has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Amit Sharma

    Indian Institute of Technology Guwahati 1 Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering Guwahati, India

    11 shared publications
  • Piruthivi Sukumar

    University of Leeds 2 Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine Leeds, United Kingdom

    11 shared publications
  • Soumik Pal

    Indian Institute of Technology Guwahati 1 Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering Guwahati, India

    11 shared publications
  • Renu Sharma

    Indian Institute of Technology Guwahati 1 Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering Guwahati, India

    10 shared publications
  • Sreeja Dattachoudhury

    Indian Institute of Technology Guwahati 1 Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering Guwahati, India

    10 shared publications
  • Amit Sharma

    Stem Cells and Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India

    8 shared publications

Latest Publications

  • Open Access

    Figure 2 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 activity modulates the expression of metalloproteinases and is required for the invasion and migration capacity of breast cancer cells. A, Representative micrographs showing the invasion of control (CON; n = 3) and PIEZO1-silenced (shPZ1; n = 4) MCF7 spheroids treated with vehicle (UNTR) or 10 μmol/L of Yoda1 (YODA1) on a collagen matrix at indicated time points. The white line in the images represents a scale bar (200 μm). B, The migration area of spheroids described in A at different time points, normalized to the initial area at t = 0 hours. Values are mean ± SD. C and D, Representative micrographs at indicated time points and a bar graph showing the average migration speed for CON and PIEZO1-silenced (shPZ1) MDA-MB-231 during the wound healing assay. The line in the images represents a scale bar (200 μm). Values are mean ± SD for n = 6 different regions. E and F, Representative micrographs and a bar graph showing the migration of CON and PIEZO1-silenced (shPZ1) MDA-MB-231 spheroids (n = 3) treated with vehicle (UNTR) or 10 μmol/L of Yoda1 (YODA1) on a collagen matrix. Values are mean ± SD. G, F-actin staining images of CON and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231 cells stained for actin (red) with phalloidin–tetramethylrhodamine isothiocyanate and nuclei (blue) with DAPI. White arrows in the middle illustrate the filopodial protrusions in CON and shPZ1 MDA-MB-231 cells. (Bottom) Monochrome images are the F-actin images of CON and shPZ1 MDA-MB-231 cells (middle); the filopodia are depicted by green lines, and filopodia density was calculated using the SNT module of ImageJ (RRID: SCR_003070). The white line in the images represents a scale bar (20 μm). H, The filopodia density of MDA-MB-231 described in G. Values are mean ± SD for n = 4 different regions. I and J, The gene expression level of EMT and migration-associated genes in CON and PIEZO1-silenced (shPZ1) MCF7 (I) and MDA-MB-231 (J). Values are mean ± SD for n = 3. P is shown for two-way repeated measures ANOVA with Sidak multiple comparisons test in B and E, and unpaired Student t test in D and H–J. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.

  • Open Access

    Figure 4 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 activity determines the self-renewal capacity of breast cancer cells by modulating the expression of stemness-related genes. A–C, The expression levels of stemness-related genes in control (CON) and PIEZO1-silenced (shPZ1) MCF7 (A) and MDA-MB-231 (B and C) were quantified using qPCR. Values are mean ± SD for n = 3. D, The expression levels of phospho-ERK1/2, β-catenin, NF-κB, phospho-STAT3, and phospho-p38MAPK were determined in CON and shPZ1 MCF7 via phospho-flow cytometry. Values are mean ± SD for n = 2. E–H, CON and PIEZO1-silenced (shPZ1) MCF7 (E and F) and MDA-MB-231 (G and H) were analyzed for the expression of β-catenin, AMPK, pERK1/2, RHOA, and BCL2 via immunoblotting. I–L, MCF7 (I and K) and MDA-MB-231 (J and L) cells cultured as 3D spheroids were analyzed for the expression of β-catenin, AMPK, phospho-ERK1/2, and RHOA via immunoblotting. Representative immunoblots and densitometric quantifications of n = 3–7 blots are shown in E–L. Values are mean ± SD. P is shown for unpaired Student t test in all the panels. *, P < 0.05; **, P < 0.005.

  • Open Access

    Data from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    Tumor cells encounter diverse mechanical forces during cancer progression, and the mechanosensitive ion channel PIEZO1 governs how breast cancer cells adapt to these cues, thereby shaping their metastatic potential. Analysis of clinical datasets revealed differential regulation of PIEZO1 between primary and metastatic breast cancers. In this study, we demonstrate that PIEZO1 regulates the proliferation, migration, and survival of breast cancer cells in a mechanosensitive environment-dependent manner. Under static conditions, optimal PIEZO1 activity is required for both proliferation and migration, which is mediated by metalloproteinases, RHOA, and S100A4. Although optimal PIEZO1 activity is required for sustained proliferation and migratory capacity, loss of PIEZO1 confers a survival advantage in triple-negative breast cancer cells under mechanically challenging conditions similar to those encountered in circulation. This phenotype was largely associated with context-specific modulation of survival pathways, including β-catenin, pERK1/2, and BCL2, indicating a mechanoenvironment-mediated rewiring of survival pathways. Chemosensitivity assays further revealed that although PIEZO1 silencing sensitized the breast cancer cells to doxorubicin in static conditions, it enhanced drug resistance in anoikis-inducing conditions. Together, these findings uncover a dual, stage-specific role for PIEZO1 in breast cancer, in which optimal PIEZO1 activity sustains proliferation and invasion, whereas PIEZO1 loss enhances cell survival under mechanostress, thereby potentiating metastatic dissemination. These results highlight PIEZO1 as a mechanosensitive protein in breast cancer, and therapeutic modulation of PIEZO1 should consider the breast cancer subtype and mechanical microenvironment for optimal therapeutic outcomes.Significance:Breast cancer cells encounter diverse mechanical forces during tumor progression and metastasis. We show that although optimal PIEZO1 activity supports growth and invasion at the primary site, its loss enhances survival and drug resistance under shear stress and anchorage-independent conditions, suggesting PIEZO1 as a stage-specific mechanotherapeutic target in breast cancer.

  • Open Access

    Figure 6 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 activity modulates β-catenin and MAPK signaling in breast cancer cells under SS conditions. A, Representative data for SS-exposed control (CON) and PIEZO1-silenced (shPZ1) MDA-MB-231 analyzed for the expression levels of β-catenin, AMPK, phospho-ERK1/2, BCL2, and RHOA via immunoblotting. B, The densiometric quantification of β-catenin, AMPK, pERK1/2, BCL2, and RHOA normalized to GAPDH levels for immunoblots described in A. Values are mean ± SD for n = 3–8 different blots. F and G, Representative immunoblots (C) and GAPDH normalized densiometric quantification (D) showing expression levels of β-catenin, p-ERK1/2, and RHOA in SS-exposed CON and PIEZO1-silenced (shPZ1) MCF7. Values are mean ± SD for n = 3–5 blots. E and F, Colony numbers obtained for CON and PIEZO1-silenced (shPZ1) MDA-MB-231 (E) and MCF7 (F) treated with vehicle (UNTR) or 10 μmol/L of BVD-523 (BVD) under AD, static suspension (SUS), or SS conditions. Values are mean ± SD for n = 3. G, Schematic summarizing the modulation of stemness and proliferation in breast cancer cells upon PIEZO1 modulation. P is shown for the Student t test in all the panels. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.

  • Open Access

    Figure 3 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 activity differentially modulates proliferation and self-renewal capacity of MCF7 and MDA-MB-231. A and B, Bar graph (A) and histogram (B) for control (CON) and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231, showing the distribution of cells in different phases of the cell cycle. Values are mean ± SD for n = 3. C and D, Spheroid growth of CON and PIEZO1-silenced (shPZ1) MCF7 (C) and MDA-MB-231 (D) treated with vehicle (UNTR) or yoda1 (YODA1) for 14 days. Values are mean ± SD for n = 4, with each dot representing an individual spheroid. E, Representative micrographs are shown for the spheroid described in C and D. The line in the images represents the scale bar (200 μm). F, Tumor formation was assessed in an in ovo CAM assay for CON and PIEZO1-silenced MCF7 and MDA-MB-231. Representative tumor images are shown. G, Tumor weights in F are shown as a percentage of control for both cell lines. Values are mean ± SD for n = 3. H and I, The number (H) and area (I) of colonies formed by CON and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231 treated with vehicle (UNTR) or Yoda1 (YODA1). Values shown are mean ± SD for n = 3 wells in H and randomly chosen n = 50 colonies in I, with each dot representing a different colony. J, Representative images of colonies obtained in H and I. The line in the images represents a scale bar (200 μm). P is shown for two-way ANOVA with Sidak multiple comparisons test in A, C, D, H, and I, and unpaired Student t test in G. *, P < 0.05; **, P < 0.005; ***, P < 0.0005; ****, P < 0.00005.

  • Open Access

    Supplementary Figure 1 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    Modulation of PIEZO1 activity alters breast cancer cell migration, proliferation, survival under mechanical stress, and sensitivity to pharmacological treatments

  • Open Access

    Figure 1 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 activation abrogates the invasion and migration capacity of breast cancer cells. A, Violin graph showing PIEZO1 expression levels across normal tissue, primary tumor, and metastatic tumor samples from TNMplot. B, Representative micrographs depict the invasion of MCF7 3D spheroids on a collagen matrix. Spheroids were treated with either vehicle (UNTR; n = 4) or 10 μmol/L of Yoda1 (YODA1; n = 3), with images captured at the indicated time points. The black line in the images represents the scale bar (200 μm). C, The migration area of the spheroids shown in B is quantified over time and normalized to the initial area at t = 0 hours. Data are presented as mean ± SD with each dot representing an individual spheroid. D, Representative micrographs of the wound healing assay at indicated time points showing migration of MDA-MB-231 treated with vehicle (UNTR) or 10 μmol/L of Yoda1 (YODA1). The white line in the images represents the scale bar (200 μm). E, Migration speed for MDA-MB-231 described in D at different time points. Values are mean ± SD for n = 3, with each dot representing a reading from a different well. F, The mRNA expression level of PIEZO1 in a panel of breast cancer cell lines relative to MCF7 cells. Values are mean ± SD for n = 3 biological replicates. G, Protein expression of PIEZO1 in different breast cancer cell lines. H, Densitometric quantification of PIEZO1 normalized to GAPDH in G, shown relative to MCF7. Values are mean ± SD for n = 3 different blots. I, The PIEZO1 mRNA expression levels in MCF7 and MDA-MB-231 transduced with lentiviral particles containing scramble RNA [control (CON)] or shPZ1. Values are mean ± SD for n = 3. J and K, The expression of the PIEZO1 protein was analyzed in CON and PIEZO1-silenced (shPZ1) MCF7 (J) and MDA-MB-231 (K). The protein expression levels were normalized to GAPDH levels in the respective conditions. L and M, The Ca2+ flux measured by indicator dye Fura2-AM in CON and PIEZO1-silenced (shPZ1) MCF7 (L) and MDA-MB-231 (M) treated with vehicle (UNTR) or 10 μmol/L of Yoda1 (YODA1). N, The mean peak Ca2+ (ΔF340/F380) values obtained in L and M. Values are mean ± SD for n = 3 wells. P is shown for two-way repeated measures ANOVA with Sidak multiple comparisons test in C and E, one-way ANOVA with Tukey multiple comparisons in F–I, and two-way ANOVA with Sidak multiple comparisons test in N. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.

  • Open Access

    Figure 5 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 downregulation promotes survival of SS-exposed breast cancer cells. A, Representative images of colonies formed by control (CON) and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231 after 24 hours of culture in static suspension (SUS) conditions. The line in the images represents a scale bar (200 μm). B and C, The colony-forming unit (CFU) number (B) and area of colonies (C) for MCF7 and MDA-MB-231 are described in A. Values are mean ± SD for n = 3 in B and mean ± SE for n = 22–50 colonies in C, with each dot representing a different colony. D, The total intracellular calcium in CON and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231, cultured under static AD or SS conditions, was measured using CTC to assess the effect of PIEZO1 silencing on shear-induced changes in calcium homeostasis. Mean ± SD is shown for n = 4. E, Representative images of colonies formed by CON and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231 after 24 hours of culture in suspension with SS exposure as described in the “Materials and Methods” section. The line in the images represents a scale bar (200 μm). F and G, The CFU number (F) and area of colonies (G) for SS-exposed MCF7 and MDA-MB-231 are described in E. Values are mean ± SD for n = 3 in F and mean ± SE for n = 40–50 colonies in G, with each dot representing a different colony. H, The representative histograms show the surface expression of stemness markers and integrins, assessed via flow cytometry, for AD cultured and SS exposed CON and PIEZO1-silenced (shPZ1) MCF7 cells. I and J, Graphs showing mean fluorescence intensity (MFI) normalized to the respective AD control condition for each marker shown in H. The values are mean ± SD. P is shown for unpaired Student t test in B, C, F, and G, and for two-way ANOVA with Sidak multiple comparisons test in D, I, and J. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.

  • Open Access

    Figure 7 from Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    PIEZO1 activity differentially modulates the chemosensitivity of breast cancer cells depending on the molecular subtype and mechanical cues. A–C, The colony-forming ability of CON and PIEZO1-silenced (shPZ1) MCF7 and MDA-MB-231 cells was assessed in the absence (UNTR) or presence of Dox with and without BVD-523 (BVD) treatment. The number (A) and total area (B) of colonies were quantified and normalized to their respective untreated controls to delineate the contribution of PIEZO1 activity to Dox-induced inhibition. D–F, The Dox-induced inhibition of clonogenic potential was further evaluated in CON and shPZ1 MCF7 and MDA-MB-231 cells cultured under suspension conditions. Colony number (D) and colony area (E) are shown as a percentage of the corresponding untreated (UNTR) condition (n = 3 wells for A and D; n = 20–30 colonies per condition for B and E). P values are shown for two-way ANOVA with Sidak multiple comparison test in all the panels. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.

  • Open Access

    Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating β-Catenin and BCL2

    by Sreeja Dattachoudhury, Amit Sharma, Renu Sharma, Soumik Pal, Piruthivi Sukumar, Bithiah Grace Jaganathan

    Tumor cells encounter diverse mechanical forces during cancer progression, and the mechanosensitive ion channel PIEZO1 governs how breast cancer cells adapt to these cues, thereby shaping their metastatic potential. Analysis of clinical datasets revealed differential regulation of PIEZO1 between primary and metastatic breast cancers. In this study, we demonstrate that PIEZO1 regulates the proliferation, migration, and survival of breast cancer cells in a mechanosensitive environment-dependent manner. Under static conditions, optimal PIEZO1 activity is required for both proliferation and migration, which is mediated by metalloproteinases, RHOA, and S100A4. Although optimal PIEZO1 activity is required for sustained proliferation and migratory capacity, loss of PIEZO1 confers a survival advantage in triple-negative breast cancer cells under mechanically challenging conditions similar to those encountered in circulation. This phenotype was largely associated with context-specific modulation of survival pathways, including β-catenin, pERK1/2, and BCL2, indicating a mechanoenvironment-mediated rewiring of survival pathways. Chemosensitivity assays further revealed that although PIEZO1 silencing sensitized the breast cancer cells to doxorubicin in static conditions, it enhanced drug resistance in anoikis-inducing conditions. Together, these findings uncover a dual, stage-specific role for PIEZO1 in breast cancer, in which optimal PIEZO1 activity sustains proliferation and invasion, whereas PIEZO1 loss enhances cell survival under mechanostress, thereby potentiating metastatic dissemination. These results highlight PIEZO1 as a mechanosensitive protein in breast cancer, and therapeutic modulation of PIEZO1 should consider the breast cancer subtype and mechanical microenvironment for optimal therapeutic outcomes. Significance: Breast cancer cells encounter diverse mechanical forces during tumor progression and metastasis. We show that although optimal PIEZO1 activity supports growth and invasion at the primary site, its loss enhances survival and drug resistance under shear stress and anchorage-independent conditions, suggesting PIEZO1 as a stage-specific mechanotherapeutic target in breast cancer.